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Abstract
Background The area of predominant per i foca l
[18F]fluorodeoxyglucose (18F-FDG) hypometabolism and re-
duced [11C]flumazenil (11C-FMZ) -binding on PET scans is
currently considered to contain the epileptogenic zone and
corresponds anatomical ly to the area local iz ing
epileptogenicity in patients with temporal lobe epilepsy
(TLE). The question is whether the volume of the perifocal
pre-operative PET abnormalities, the extent of their resection,
and the volume of the non-resected abnormalities affects the
post-operative seizure outcome.
Methods The sample group consisted of 32 patients with me-
sial temporal sclerosis who underwent anteromedial temporal
lobe resection for refractory TLE. All patients had pathologic
perifocal findings on both of the PET modalities as well as on
the whole-brain MRI. The volumetric data of the PET and
MRI abnormalities within the resected temporal lobe were
estimated by automated quantitative voxel-based analysis.
The obtained volumetric data were investigated in relation to
the outcome subgroups of patients (Engel classification) de-
termined at the 2-year post-operative follow-up.
Results The mean volume of the pre-operative perifocal 18F-
FDG- and 11C-FMZ PET abnormalities in the volumes of
interest (VOI) of the epileptogenic temporal lobe, the mean
resected volume of these PETabnormalities, the mean volume
of the non-resected PET abnormalities, and the mean MRI-
derived resected volume were not significantly related to the
outcome subgroups and had a low prediction for individual
freedom from seizures.
Conclusions The extent of pre-surgical perifocal PET abnor-
malities, the extent of their resection, and the extent of non-
resected abnormalities were not useful predictors of individual
freedom from seizures in patients with TLE.
Keywords Temporal lobe epilepsy . 18F-FDG-PET .
11C-FMZ-PET . Post-operative outcome
Introduction
Temporal lobe epilepsy (TLE) is the most common partial
seizure syndrome in adults. TLE is, unfortunately, often
refractory to optimal pharmacological treatment [44]. Ev-
idence suggests that surgical treatment offers the possibil-
ity of freedom from seizures for these patients [10]. How-
ever, it is unknown why a relatively large proportion of
patients continue to experience seizures after surgery
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despite careful pre-surgical work-up and selection. Fur-
thermore, the predictors for individual freedom from sei-
zures in patients with TLE are not fully understood.
The common view is that an accurate pre-surgical lat-
eralization and localization of epileptogenic zone in pa-
tients with drug-resistant TLE is essential for postopera-
tive seizure freedom. However, identifying the epilepto-
genic zone can be complex and may require a constella-
tion of findings from multimodal evaluation methods.
Interictal [18F]fluorodeoxyglucose (18F-FDG) PET, an in-
dex of the cerebral metabolism rate of glucose, and
interictal [11C]flumazenil-binding (11C-FMZ) PET, an in-
dex of the binding potential of brain benzodiazepine re-
ceptors, are widely used as helpful functional neuroimag-
ing tools of non-invasive localization and characterization
of epileptogenic regions [17, 18, 25, 26, 29, 30, 49, 55].
Because it has been shown that the interictal 18F-FDG
PET usually shows a large area of reduced radiotracer
uptake (hypometabolism) extending beyond the epilepto-
genic zone [1, 24] and the interictal 11C-FMZ PET may
show a more restricted area of decreased tracer binding
[31, 40] in patients with refractory TLE, these neuroim-
aging modalities can be used for lateralization and general
localization of the seizure focus, making an a priori hy-
pothesis about subsequent intracranial electrode place-
ment possible [28]. However, research on the relationship
between the extent of the resection of PET abnormalities
and outcomes in patients with refractory TLE has been
less of focus [53].
The area of predominant glucose hypometabolism in
the temporal lobe is currently considered to contain the
epileptogenic zone [33, 51] and corresponds anatomically
to the area localizing epileptogenicity [45]. Furthermore,
it is assumed that the area of localized reduction of 11C-
FMZ binding correlates closely with the side and site of
seizure onset [38, 47]. Therefore, the question is whether
the volume of the perifocal pre-operative PET abnormal-
ities, the extent of their resection, and the volume of the
non-resected abnormalities affects the post-operative sei-
zure outcome. This study was designed to investigate the
relationship between these volumetric data of 18F-FDG-
and 11C-FMZ PET abnormalities that occurred in the ep-
ileptogenic temporal lobe and were accessible for resec-
t ion and the pos t -surg ica l se izure outcome of
anteromedial temporal lobectomy (AMTL) in the TLE
patients with mesial temporal sclerosis. We also quanti-
tatively determined the magnetic resonance imaging
(MRI)-derived resected volumes of the temporal lobe
and analyzed whether this value was associated with
post-operative seizure outcome. It should be noted that
this study was not designed to indicate the feasibility of
18F-FDG- and 11C-FMZ PET investigations in pre-
surgical work-up.
Materials and methods
The study was approved by the Regional Ethical Committee
of Health Region in South-East Norway (2012/1989/REK) for
the study of human subjects.
Patients
Between July 2002 and April 2008 at the Department of Neu-
rosurgery at Oslo University Hospital, Norway, 107 patients
with medically refractory TLE underwent unilateral AMTL.
Among these patients, 39 with a previous temporal lobe sur-
gery or presence of a tumor, vascular lesion, cortical develop-
mental anomaly, and encephalomalacia were excluded for this
study. We identified 68 patients in which MRI and histopath-
ologic examinations revealed hippocampal sclerosis. Thirty-
six patients of these 68 were not included in the study because
they did not fulfil the required inclusion criteria. Determina-
tion of the presence of PET abnormalities was performed by
visual inspection and a semi- quantitative method of interpre-
tation with the interpreter comparing any hemispheric asym-
metry with a normal 18F-FDG- and 11C-FMZ PET brain pat-
tern. Patients with bilateral temporal lobe PET abnormalities,
based on this evaluation, were not included in this cohort
because the implemented automated method of PET image
analysis detailed below precludes the detection of bilateral
PET abnormalities in homologous temporal lobe regions.
The rest, 32 patients, who had 18F-FDG- and 11C-FMZ PET
neuroimaging performed as part of the pre-surgical evalua-
tion, pre- and post-surgical high-resolution whole-brain
MRI, and post-operative seizure outcome determined at the
2-year post-operative follow-up were included in this study.
Pre-surgical evaluation included seizure history and semi-
ology, neurological examination, long-term video EEG mon-
itoring, brain MRI, neuropsychological examinations, and
interictal 18F-FDG- and 11C-FMZ PET imaging. When appro-
priate, ictal and interictal brain single-photon emission com-
puted tomography (SPECT) was also performed. On the basis
of these multimodal investigations, the diagnosis of TLE was
confirmed, and localizing information was reviewed at the
pre-surgical planning meeting.
EEG protocol and assessment
Pre-operatively, long-term interictal and ictal scalp EEGs were
recorded by a video EEG monitoring system in all patients,
with 25 or 64 electrodes placed according to the international
10–10 system. In addition, 56 % (18 out of 32) patients had
long-term intracranial EEG and video recordings with surgi-
cally placed subdural strip electrodes (including all patients
with discordant localization information from other modalities
of evaluation) to confirm the epileptogenic zone before under-
going the temporal lobe resection. The subdural electrode
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placements were guided by seizure semiology, probable sei-
zure onset area as determined by scalp interictal and ictal
EEGs, and 18F-FDG- and 11C-FMZ PET abnormalities. Mul-
tiple ictal recordings were obtained during seizures typical for
the patient and the temporal lobe of seizure onset was defined.
The seizure onset temporal lobe and seizure onset zone were
identified by identifying seizure onset, early seizure spread
(defined as areas involved in seizure activity less than 10 s
after onset of the seizure) and dominant interictal epileptiform
activity consisting of sharp and slow wave components.
MRI acquisition and qualitative visual assessment
Pre-surgical high-resolution whole-brain MRI examinations
were carried out using a TLE protocol on a 1.5-Tesla scanner
(Avanto, Siemens, Erlangen, Germany) with a 12-channel
headcoil. The following sequences were obtained: 3D T1-
weighted MP RAGE (TR/TE 1900/3.46), flip angle of 15
degrees, slice thickness 1.25 mm, and FOV 250; coronal
FLAIR (TR/TI/TE 9000/2500/108) slice thickness 3 mm,
FOV 230, and axial T2-weighted (TR/TE 4050/98) slice
thickness 5 mm, FOV 230. Pre-operatively, all MR images
were reviewed by a neuroradiologist with specific expertise
in epilepsy studies using accepted criteria. The presence of
hippocampal sclerosis on MRI scans (predominant unilateral
atrophy and increased T2 signal in the hippocampus) were
determined. Similar sequences were also obtained post-oper-
atively, 6 months after surgery, to confirm the extent of the
AMTL.
Qualitative visual radiological assessment of the pre-
surgical MRI studies in these patients demonstrated mesial
temporal sclerosis localized to the resected temporal lobe in
all included patients (Table 1).
18F-FDG- and 11C-FMZ PETacquisition and pre-surgical
evaluation
Interictal (no seizures within the last 24 h) out-patient 18F-
FDG- and 11C-FMZ PET scans were acquired at the Univer-
sity Hospital in Uppsala, Sweden. The patients underwent a
40-min dynamic scan after intravenous administration of
4 MBq/kg 11C-FMZ and a 20-min static scan 30 min after
the i.v. administration of 3 MBq/kg 18F-FDG on the same
day. The images were acquired using an ECAT Exact HR+
scanner (Siemens/CTI, Knoxville, TN, USA) and reconstruct-
ed using normalization and attenuation-weighted ordered sub-
sets expectation maximization (six iterations and eight sub-
sets) after applying all appropriate corrections. The recon-
struction process created a standard series of contiguous im-
ages oriented in the transaxial, coronal, sagittal, and
transtemporal planes. Evaluation and reporting of imaging
data were performed by experienced nuclear medicine physi-
cians. Images were evaluated visually and with a semi-
quantitative method with measurements of inter-hemispheric
asymmetries. All significant findings were reported without or
with limited access to the previous pre-surgical investigation.
Routine EEG monitoring to confirm that no seizure occurred
during acquisition was not performed.
This evaluation of the pre-surgical 18F-FDG -and 11C-FMZ
PET studies in these patients revealed that 31 patients (97 %)
had decreased glucose metabolism and 26 patients (81 %) had
decreased 11C-FMZ binding that occurred in the temporal lobe
of seizure onset in accordance with the EEG results, which are
considered perifocal PET abnormalities in this study. In addi-
tion, remote PET abnormalities that extended either contigu-
ously beyond the resected temporal lobe (into the adjacent
Table 1 Demographic and clinical profile of 32 patients with drug-
resistant complex partial seizures of temporal lobe origin with or without
secondary generalization
Characteristic n (%) or median
(min-max)
Gender
Female 21 (66 %)
Male 11 (34 %)
Etiological
Febrile convulsion 8 (25 %)
Meningitis 2 (6 %)
Unknown 22 (69 %)
Age onset (years)
Median (min-max) 7 (1–34)
Duration of epilepsy before surgery (years)
Median (min-max) 24 (6–54)
Age Surgery (years)
Median (min-max) 35 (10–55)
MRI results
Structural finding localized to the temporal lobe 32 (100 %)
EEG seizure onset defined by
Scalp EEG 14 (44 %)
Intracranial EEG 18 (56 %)
Resected temporal lobe
Left 20 (62 %)
Right 12 (38 %)
Histopathological findings in hippocampus/neocortex
Hippocampal sclerosis/no pathologic* 32 (100 %)
Seizure outcome score at 2-year follow-up (Engel’s class)
Class I 25 (78 %)
Class II 1 (3 %)
Class III 2 (6 %)
Class IV 4 (13 %)
Data presented as number of patients (%) or median (min-max)
*The specimens with hippocampal sclerosis are considered pathologic,
whereas the specimens with gliosis only are considered as not pathologic
findings
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lobe) or presented as remote ipsilateral and/or contralateral
PET abnormalities (outside of the resected lobe and not con-
tinuous with the resected temporal lobe) were found in 21
patients (66 %) on 18F-FDG and 18 (56 %) on 11C-FMZ
PET. Such remote PET abnormalities were not included in
neuroimaging post-processing and quantitative analyses in
this study.
Surgery, histology, and postoperative seizure outcome
All patients subsequently underwent an AMTL under general
anesthesia . Five of them, in which pre-surgical
neuropsychometric memory tests were not affected, had un-
dergone a tailored AMTL of the dominant hemisphere. One of
the four neurosurgeons using similar microsurgical resection
techniques performed the surgical procedures. The anterior
temporal lobe was removed, with an en bloc excision of neo-
cortical structures that were submitted to histopathological
examination, followed by resection of the amygdala, and sub-
sequent en bloc resection of the parahippocampal gyrus and
hippocampus that were also submitted to histopathological
examination. The extent of lateral neocortical resection along
the long axis of the temporal lobe included the superior tem-
poral gyrus limited to approximately 2 cm from the temporal
tip and the middle, inferior, and fusiform temporal gyri 3.5 to
5 cm from the temporal tip as measured at the time of surgery.
The medial temporal lobe resection included endopial empty-
ing of the uncus and en bloc resection of the parahippocampal
gyrus medially to the tentorial incisura and the hippocampus
with fimbria followed by generous resection of the amygdala.
The hippocampus resection extended posteriorly to the poste-
rior margin of the midbrain and exposure of the anterior por-
tion of the ventricular atrium (approximately 2.5 to 3 cm from
the pes hippocampi anterior tip in the temporal horn posteri-
orly along its length). The margins of the AMTL were not
based on the extent of 18F-FDG- and 11C-FMZ PET abnor-
malities unless there was corresponding epileptiform EEG
abnormality occurring over the temporal lobe.
The resected specimens were histopathologically examined
by a neuropathology expert using a standard protocol for ep-
ilepsy surgery cases. In brief, surgical specimens from the
neocortex and hippocampus were fixed in formalin and sec-
tioned perpendicularly to the cortical surface into several tis-
sue blocks. All the tissue blocks from the neocortex and the
hippocampus were embedded in paraffin and stained with
hematoxylin and eosin (H&E) and Luxol fast blue. Various
immunostains (such as GFAP, myelin basic protein,
pho spho ry l a t ed neu ro f i l amen t p r o t e i n , NeuN ,
synaptophysin, and αB-crystallin) were applied where neces-
sary to clarify the nature of the pathology. The result of the
histopathological examination is presented in Table 1.
Postoperative seizure outcome at the 2-year follow-up
(Table 1) was determined by experienced neuropsychology
experts according to the Engel classification [11] . For analysis
in this cohort, seizure outcome data were dichotomized into
Engel class I outcome and Engel class II–IVoutcome.
Neuroimaging post-processing and quantitative
automated voxel-based analyses
The steps involved in the post-processing of the images are
summarized in Fig. 1. All post-acquisition imaging processing
and analyses were carried out by a single operator blinded to
the post-surgical seizure outcome. T1-weighted MPRAGE
MR image slices in DICOM format were converted into a
single 3D volume and the PET images in ECAT format were
converted into a single 3D volume. The initial volume dimen-
sions of the T1-weighted MPRAGE MR volume were 512×
512×160 with a voxel size of 0.49×0.49×1.25 mm3. The
initial volume dimension of 18F-FDG PET and 11C-FMZ
PET was 128×128×63 with a voxel size of 2.06×2.06×
2.43 mm3.
Estimation of resection volume extent in the temporal lobe
of seizure onset using pre- and post-surgical MRI Pre- and
post-surgical high-resolution MR volumes (Fig. 1c and d)
were segmented using Freesurfer 5.1.0 [13, 14]. The
surface-based segmentation tool estimates the region to which
each voxel of the input MRI most probably belongs, generates
as output a label volume containing one label (region) per
voxel (Fig. 1g and i) and calculates the cortical thickness
and volume for each label. In the same process, the original
MRI volumes were re-sliced to an isotropic voxel size
(1 mm3).
The resected volume in the temporal lobe of seizure onset
was automatically calculated by the following procedure. The
post-surgical volume was registered using a rigid registration
approach [36] (Fig. 1h) and the calculated transformation ma-
trix was applied to the post-surgical labels (Fig. 1m). Both pre-
and post-surgical labels were converted to binary volumes and
morphological operations (closing) were applied to fill unas-
signed voxels (Fig. 1l and q). After this step, voxel-by-voxel
subtraction between pre- and post-surgical MRI binary vol-
umes (equivalent to a set difference of post-surgical and pre-
surgical volume) was performed (Fig. 1p). This difference
corresponded to the volumetric resected area in the temporal
lobe of seizure onset, which was more accurately obtained
after morphological opening to remove non-resected areas
that appeared in the resection volume due to co-registration
error.
Definition of volumes of interests using pre- and post-
surgical MRI Two volumes of interest (VOIs) on the pre-
surgical MRI binary image were automatically defined in the
right and left temporal lobe as follows: (1) the medial gather-
ing of the amygdala, hippocampus, and parahippocampal
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gyrus (VOIA+H+PH) and (2) the whole temporal lobe
consisting of neocortex of the superior temporal, middle tem-
poral, inferior temporal, fusiform, temporal pole, transverse
temporal cortical areas, entorhinal parahippocampal, hippo-
campus, and amygdala structures (VOITL). When cortical
areas were included in the VOI, both the cortical ribbon and
subcortical white matter (within 5 mm from the cortical rib-
bon) were included in the definition of the VOI.
Pre-surgical volumes of these two VOIs were calculated by
summing the individual volumes extracted from the pre-
surgical MR label volume (Fig. 1g). Calculations of the
post-surgical volumes of VOIs in the resected temporal lobe
were performed with a different method because many as-
sumptions of Freesurfer algorithms would be violated by
resected MR images. To overcome this problem, a derived
post-surgical label volume was estimated by voxel-by-voxel
subtraction of the pre-surgical label volume (Fig. 1g) and the
estimated resected volume (resVol) (Fig. 1p). Using this de-
rived post-surgical MR label volume, the post-surgical vol-
umes of these two VOIs in the temporal lobe of seizure onset
were calculated by summing the individual volumes extracted
from the derived post-surgical MR label volume.
Estimation of pre-surgical 18F-FDG hypometabolism and
decreased 11C-FMZ binding in the VOIs of the epilepto-
genic temporal lobe Dynamic 11C-FMZ was averaged be-
tween the tenth and 20th minutes of the experiment to create
a static 11C-FMZ volume. Both the static 18F-FDG (Fig. 1a)
and 11C-FMZ (Fig. 1n) volumes were rigidly co-registered to
the pre-surgical MRI using a boundary-based registration al-
gorithm [15] (Fig. 1e and f) and re-sliced in the pre-surgical
space. At this stage, the pre-surgical MRI label volume of
VOIs, volumetric resected area of VOIs and 18F-FDG- and
11C-FMZ PET images were in the same space, allowing
voxel-by-voxel operations between these volumes.
The 18F-FDG-and 11C-FMZ PET abnormality areas that
lay within the VOIs of epileptogenic temporal lobe ipsilateral
to the resected side were defined by the following voxel-based
procedure. The mean uptake of both tracers in each defined
VOI (VOIA+H+PH or VOITL) was calculated contralateral from
Fig. 1 Schematic of the post-processing of the MR and PET images. a
Raw static 18F-FDG. bRaw static 11C-FMZ. c Pre-operativeMRI. d Post-
operative MRI. e 11F-FDG image co-registered to the pre-operative MRI.
f 11C-FMZ image co-registered to the post-operative MRI. g Labeled (or
segmented) pre-operativeMRI. h Post-operativeMRI co-registered to the
pre-operative MRI. i Labeled (or segmented) post-operative MRI. j
Temporal lobe 18F-FDG abnormality overlaid on the co-registered 18F-
FDG image. k Temporal lobe 11C-FMZ abnormality overlaid on the co-
registered 11C-FMZ image. l Binary map of the skull-stripped pre-
operative MRI. m Labeled (or segmented) post-operative MRI co-
registered to the pre-operative MRI. n Resected area overlaid on the
temporal lobe 18F-FDG abnormality overlaid on the co-registered 18F-
FDG image. o Resected area overlaid on the temporal lobe 11C-FMZ
abnormality overlaid on the co-registered 11C-FMZ image. p Estimated
resected area. q Binary map of the skull-stripped co-registered post-
operative MRI
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the resected side (ŪA+H+PH orŪTL). Each voxel of the VOI on
the epileptogenic resected side (ures) were then compared to
the contralateral mean and voxels with uptake 10 % less than
the contralateral mean were defined as marked Bperifocal^
PET abnormalities that occurred in the temporal lobe on
resected side (see Fig. 2. Algorithm 1). As an output of this
algorithm, four pre-surgical abnormality volumes
(PreAbnVol) were created in the epileptogenic temporal lobe,
one per tracer and per VOI (PreAbnVol18F-FDGA+H+PH,
PreAbnVol18F-FDGTL, PreAbnVol
11C-FMZA+H+PH, and
PreAbnVol11C-FMZTL). The definition of abnormalities was
implemented using Matlab 2009a (The MathWorks, Inc., Na-
tick, MA, USA). This procedure allowed the definition of pre-
surgical perifocal 18F-FDG- and 11C-FMZ PET abnormalities
in the VOIs of the epileptogenic temporal lobe based on an
asymmetry index derived from contralateral homotopic VOIs
in the temporal lobe.
Estimation of non-resected volume of 18F-FDG- and 11C-
FMZ PET abnormalities in VOIs using voxel-by-voxel
comparison The extent of the 18F-FDG and 11C-FMZ abnor-
malities was calculated by counting the number of abnormal
voxels in each pre-surgical PET abnormality volume. The ex-
tent of non-resected perifocal 18F-FDG and 11C-FMZ abnor-
mality volumes in VOIs was calculated as the relative com-
plements (or set difference) between the abnormality volumes
and the resection volume using the following algorithm:
nonResAbnVol ¼ abnVolnresVol ¼ χ∈abnVoljχ∉resVolf g
As an output of this algorithm, four non-resected abnormal-
ity volumes (nonResAbnVol) were created in the epileptogen-





FMZTL). The non-resected volumes of the
18F-FDG- and
11C-FMZ PET abnormalities were expressed as a percentage
of the total marked PET abnormality volume in VOIs.
Statistical analysis
All statistical analyses were performed with SPSS, version
21.0, (IBM Corporation, Armonk, NY, USA). The data were
described as number and percentage or mean and standard
deviation unless stated otherwise. The difference in volumes
between perifocal 18F-FDG PET and 11C-FMZ PET abnor-
malities in the corresponding VOIs were statistically analyzed
using a paired-samples t test. Patients with a satisfactory
(Engel class I) and unsatisfactory (Engel classes II–IV) post-
surgical outcome were compared using an independent sam-
ples t test for the following five variables: (i) the pre-surgical
volume of the present perifocal 18F-FDG hypometabolism
and decreased 11C-FMZ binding in the VOIA+H+PH and
VOITL; (ii) the volume of the resected perifocal
18F-FDG
hypometabolism and decreased 11C-FMZ binding that lay in
the VOIA+H+PH and VOITL; (iii) the percentage of the non-
resected perifocal 18F-FDG hypometabolism and decreased
11C-FMZ binding that present in the VOIA+H+PH and VOITL
after resection; (iv) the MRI-derived resected tissue volume in
the VOIA+H+PH and VOITL; (v) the percentage represented by
the resected MRI-defined volume within the VOIA+H+PH and
VOITL.
To assess the possible influence of all five variables on the
achievement of a satisfactory (Engel class I) post-surgical sei-
zure outcome, we analyzed the data with logistic regression
and estimated odds ratio (OR) and corresponding C-statistic
(equivalent to the area under the receiver operating character-
istics curve). For all tests, p<0.05 was considered to be a
statistically significant difference between the groups.
Results
The cohort consisted of 32 patients (21 female and 11 male)
with a median age of 35 years (min 10–max 55). At the latest
follow-up (2 years after surgery), 78 % of patients (25 out of
32) had an Engel class I outcome (i.e., free of disabling sei-
zures) of whom 56 % (18 out of 32) had Engel class IA
outcome (i.e., completely seizure free) and 22 % (seven out
of 32) Engel class IB outcome (i.e., nondisabling simple par-
tial seizures only). Seven (22 %) of 32 patients had unsatis-
factory post-surgical outcome (Engel class II–IV). The base-
line demographic and clinical features of the patients are sum-
marized in Table 1.
The results of the automated quantitative 18F-FDG-
and 11C-FMZ PET analysis
The quantitative voxel-based evaluation of the pre-surgical
18F-FDG- and 11C-FMZ PET studies in the patients revealed
that all 32 patients (100 %) had perifocal 18F-FDG
hypometabolism and decreased 11C-FMZ binding in the
Fig. 2 Algorithm 1: Classification of PET voxels ipsilateral to the
resected side
1910 Acta Neurochir (2015) 157:1905–1916
epileptogenic temporal lobe ipsilateral to the resected side. In
the study, the mean pre-surgical perifocal volume of the 18F-
FDGPETabnormality in the VOIA+H+PHwas not significantly
different from the 11C-FMZ PET abnormality volume (p=
0.178). However, in the VOITL, the mean pre-surgical
perifocal volume of the 18F-FDG PET abnormality was sig-
nificantly larger than the 11C-FMZ PET abnormality volume
(p<0.001).
In the VOIA+H+PH, the mean resected volume of the
perifocal 18F-FDG PET abnormality was significantly higher
than the resected volume of the perifocal 11C-FMZ PET ab-
normality (p=0.005). Similarly, the mean resected volume of
the perifocal 18F-FDG PET abnormality in the VOITL was
significantly higher than the mean resected volume of the
perifocal 11C-FMZ PET abnormality (p<0.001).
In the VOIA+H+PH, the percentage of the resected volume of
the perifocal 18F-FDG PET abnormality of 19 % was signifi-
cantly higher than the percentage of the resected volume of the
perifocal 11C-FMZ PET abnormality of 14 % (p<0.001).
Similarly, in the VOITL, the percentage of the resected volume
of the perifocal 18F-FDG PET abnormality of 43 % was sig-
nificantly higher than the percentage of the resected volume of
the perifocal 11C-FMZ PET abnormality of 37 % (p<0.001).
Following resection, in the Engel class I and Engel class II–
IVoutcome subgroups of patients, the mean pre-surgical vol-
umes of perifocal 18F-FDG-and 11C-FMZ PET abnormalities
were statistically significantly reduced in the VOIA+H+PH
(Table 2) and the VOITL (Table 3).
However, the volume of perifocal 18F-FDG PET and 11C-
FMZ PET abnormalities in the VOIA+H+PH before resection,
the resected abnormality volume, and the percentage of non-
resected abnormality volumes were not significantly different
in the Engel class I outcome subgroup compared with the
Engel classes II–IVoutcome subgroup (Table 4).
The volume of perifocal 18F-FDG PET abnormality in the
VOITL before resection was significantly higher in the Engel
class I outcome subgroup compared with the Engel classes II–
IV outcome subgroup (Table 5). On the other hand, the
Table 2 Comparisons of the mean pre-surgical and post-surgical volumes of perifocal 18F-FDG PETand 11C-FMZ PETabnormalities in the VOIA+H+





n Volume of abnormality
mean (SD) (mm3)
Volume of resected abnormality
mean (SD) (mm3)
95 % CI p value
18F-FDG
Before resection Class I 25 3221 (1537) 712 (1053) 277–1146 0.002
After resection 2509 (868)
Before resection Class II–IV 7 3007 (1344) 521 (367) 181–860 0.009
After resection 2486 (1114)
11C-FMZ
Before resection Class I 25 3101 (617) 428 (435) 248–608 <0.001
After resection 2673 (574)
Before resection Class II–IV 7 2685 (691) 447 (369) 106–788 0.018
After resection 2238 (585)
VOI volume of interest, A+H+PH Amygdala+Hippocampus+Parahippocampal gyrus, N number of patients
Table 3 Comparisons of the mean pre-surgical and post-surgical volumes of perifocal 18F-FDG PET and 11C-FMZ PET abnormalities in the VOITL





n Volume of abnormality
mean (SD) (mm3)
Volume of resected
abnormality mean (SD) (mm3)
95 % CI p value
18F-FDG
Before resection Class I 25 33,358 (7224) 14,461 (4751) 12,500–16,422 <0.001
After resection 18,896 (5670)
Before resection Class II–IV 7 27,460 (4738) 12,518 (4848) 8035–17,001 <0.001
After resection 14,942 (3761)
11C-FMZ
Before resection Class I 25 25,469 (6175) 9203 (3225) 7871–10,534 <0.001
After resection 16,266 (4966)
Before resection Class II–IV 7 22,609 (3985) 8952 (3575) 5646–12,259 <0.001
After resection 13,657 (3475)
VOI volume of interest, TL whole temporal lobe, n number of patients
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volume of 11C-FMZ PET abnormality in the VOITL before
resection was not significantly different in the Engel class I
outcome subgroup compared with the Engel classes II–IV
outcome subgroup (Table 5). However, the resected volume
of perifocal 18F-FDG PETand 11C-FMZ PETabnormalities in
the VOITL and the percentage of non-resected abnormality
volumes were not significantly different in the Engel class I
outcome subgroup compared with the Engel classes II–IV
outcome subgroup (Table 5).
The odds ratio from logistic regression of the pre-surgical
volumes of perifocal 18F-FDG PETand 11C-FMZ PET abnor-
malities in the VOIA+H+PH and VOITL, the resected
Table 4 Comparisons of the mean pre-surgical volumes of perifocal
18F-FDG- and 11C-FMZ PET abnormalities in the VOIA+H+PH, resected
volumes of perifocal PET abnormalities, percentages of non-resected
perifocal PET abnormalities, and the MRI-derived mean resected
volume and percentage this volume represents between seizure outcome
subgroups Engel class I vs. classes II–IV
18F-FDG-and 11C-FMZ
PET and MRI in VOIA+H+PH
Seizure outcome
scores (Engel class)
n Volume of abnormality
mean (SD) (mm3 or %)
Differences
mean (mm3 or %)
95 % CI p value
18F-FDG pre-surgical volume Class I 25 3221 (1537) 214 −1096–1525 0.740
Class II–IV 7 3007 (1344)
18F-FDG resected volume Class I 25 712 (1053) 191 −644–1026 0.643
Class II–IV 7 521 (367)
18F-FDG percentage of non-resected abnormality Class I 25 82 (14) 1 −11–13 0.875
Class II–IV 7 81 (11)
11C-FMZ pre-surgical volume Class I 25 3101 (618) 416 −137–969 0.135
Class II–IV 7 2685 (691)
11C-FMZ resected volume Class I 25 428 (436) −19 −388–350 0.917
Class II–IV 7 447 (369)
11C-FMZ percentage of non-resected abnormality Class I 25 87 (12) 3 −7–13 0.535
Class II–IV 7 84 (10)
MRI-derived volume resected Class I 25 1572 (1316) 63 −1000–1126 0.905
Class II–IV 7 1509 (693)
MRI percentage of resected volume Class I 25 19 (15) −2 −14–11 0.781
Class II–IV 7 20 (10)
VOI volume of interest, A+H+PH Amygdala+Hippocampus+Parahippocampal gyrus and uncus, n number of patients
Table 5 Comparisons of the mean pre-surgical volumes of perifocal
18F-FDG- and 11C-FMZ PET abnormalities in the VOITL , resected
volumes of perifocal PET abnormalities, percentages of non-resected
perifocal PET abnormalities and the MRI-derived mean resected
volume and percentage this volume represents between seizure outcome
subgroups Engel class I vs. class II–IV
18F-FDG-and 11C-FMZ
PET and MRI in VOITL
Seizure outcome
scores (Engel class)
n Volumes of abnormality
mean (SD) (mm3 or %)
Differences
mean (mm3 or %)
95 % CI p value
18F-FDG pre-surgical volume Class I 25 33,358 (7224) 5898 −41–11,836 0.052
Class II–IV 7 27,460 (4738)
18F-FDG resected volume Class I 25 14,462 (4751) 1943 −2223–6109 0.348
Class II–IV 7 12,518 (4848)
18F-FDG percentage of non-resected abnormality Class I 25 57 (11) 2 −8–12 0.724
Class II–IV 7 55 (11)
11C-FMZ pre-surgical volume Class I 25 25,469 (6175) 2859 −2209–7928 0.258
Class II–IV 7 22,610 (3985)
11C-FMZ resected volume Class I 25 9203 (3226) 250 −2630–3131 0.860
Class II–IV 7 8953 (3575)
11C-FMZ percentage of non-resected abnormality Class I 25 64 (10) 3 −6–12 0.503
Class II–IV 7 61 (11)
MRI-derived volume resected Class I 25 19,647 (5782) 1650 −3426–6725 0.512
Class II–IV 7 17,997 (5928)
MRI percentage of resected volume Class I 25 27 (8) 0 −7–7 0.941
Class II–IV 7 27 (8)
VOI volume of interest, TL whole temporal lobe, n number of patients
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abnormality volumes and the percentage of non-resected ab-
normality volumes were not significant and had a low predic-
tion for Engel class I outcome for each individual patient as
assessed by estimation of the C-statistic (Tables 6 and 7).
The results of the automated quantitative analysis
of the MRI-derived resected volume
There was a marked difference between the mean volume of
tissue resected in the VOIA+H+PH between the right and left
sides (2226±1328 mm3 vs. 1187±913 mm3, p=0.006) and in
the mean volume of tissue resected in the VOITL when com-
paring the right and left side (22,136±7344 mm3 vs. 17,568±
4392 mm3, p=0.020).
The post-surgical seizure outcome subgroups were not in-
fluenced by the volume of the MRI-derived resected brain
tissue and the percentage this resected volume represented in
the VOIA+H+PH and VOITL (Tables 4 and 5). The odds ratios
from logistic regression of the volume of MRI-derived
resected brain tissue and the percentage the resected volume
represented in the VOIA+H+PH and VOITL were not significant
and had a low prediction for Engel class I outcome for each
individual patient as assessed by estimation of the C-statistic
(Tables 6 and 7).
Discussion
Anterior temporal lobectomy (ATL) has been established as
an effective treatment option for patients with drug-resistant
TLE, leading, in most reported series, to Engel class I seizure
outcome (free of disabling seizures) in 60–80% of patients [2,
4, 8, 12, 34, 35, 54]. The post-surgical seizure outcomes here
are comparable with the data in the literature.
According to our best knowledge, this study is the first that
examined by the automated quantitative voxel-based analysis
whether the pre-surgical volume of perifocal 18F-FDG- and
11C-FMZ PET abnormalities in the VOIA+H+PH and VOITL,
the extent of resection of the region of these abnormalities, and
the percentage of the non-resected perifocal abnormality
Table 6 Odds ratios from logistic regression of the pre-surgical
volumes of perifocal 18F-FDG- and 11C-FMZ PET abnormalities in the
VOIA+H+PH , resected volumes of perifocal PET abnormalities,
percentages of non-resected perifocal PET abnormalities and the MRI-
derived mean resected volume and percentage this volume represents on
probability of Engel class I outcome
18F-FDG-and 11C-FMZ PET, and MRI in VOIA+H+PH Odds ratio 95 % CI p value C-statistic area under ROC curve
18F-FDG pre-surgical volume 1.0001 0.9995–1.0007 0.731 0.49
18F-FDG resected volume 1.0002 0.9991–1.0015 0.639 0.43
18F-FDG percentage of non-resected abnormality 1.0051 0.9446–1.0696 0.870 0.56
11C-FMZ pre-surgical volume 1.0007 0.9996–1.0018 0.204 0.62
11C-FMZ resected volume 1.0000 0.9978–1.0018 0.914 0.56
11C-FMZ percentage of non-resected abnormality 1.0229 0.9540–1.0968 0.524 0.63
MRI-derived volume resected 1.0000 0.9993–1.0007 0.901 0.45
MRI percentage of resected volume 0.9912 0.9338–1.0522 0.773 0.60
VOI volume of interest, A+H+PH Amygdala+Hippocampus+Parahippocampal gyrus
Table 7 Odds ratios from logistic regression of the pre-surgical
volumes of perifocal 18F-FDG- and 11C-FMZ PET abnormalities in the
VOITL , resected volumes of perifocal PET abnormalities, percentages of
non-resected perifocal PET abnormalities and the MRI-derived mean
resected volume and percentage this volume represents on probability
of Engel class I outcome
18F-FDG- and 11C-FMZ PET and MRI in VOITL Odds ratio 95 % CI p value C-statistic area under ROC curve
18F-FDG pre-surgical volume 1.0001 0.9999–1.0003 0.063 0.74
18F-FDG resected volume 1.0000 0.9999–1.0002 0.340 0.64
18F-FDG percentage of non-resected abnormality 1.0140 0.9412–1.0923 0.714 0.54
11C-FMZ pre-surgical volume 1.0001 0.9999–1.0003 0.259 0.60
11C-FMZ resected volume 1.0000 0.9997–1.0002 0.855 0.59
11C-FMZ percentage of non-resected abnormality 1.0281 0.9499–1.1127 0.491 0.55
MRI-derived volume resected 1.0000 0.9998–1.0002 0.500 0.61
MRI percentage of resected volume 1.0041 0.9033–1.1162 0.939 0.52
VOI volume of interest, TL whole temporal lobe
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volume affected the post-surgical seizure outcomes. Addition-
ally, we examined by the automated quantitative voxel-based
analysis whether the MRI-derived resected volume of brain
tissue of both VOIs influenced the post-surgical seizure out-
come. A relatively small group of patients in this study is the
most important limitation.
The most commonly used cerebral PET tracer in TLE is
18F-FDG, which measures glucose metabolism related to the
synaptic and neuronal activity of the brain tissue [37]. Another
cerebral PET tracer used to detect the epileptic brain region in
patients with TLE is 11C-FMZ, which binds to α subunits of
the γ-aminobutyric acid A benzodiazepine receptor. De-
creased 11C-FMZ binding on interictal PET scans usually rep-
resents neuronal loss or receptor changes related to
epileptogenicity [6, 9, 23, 31]. The majority of patients with
refractory TLE exhibit on pre-operative 18F-FDG- and 11C-
FMZ PET scans perifocal abnormalities of epileptogenic tem-
poral lobe that may affect the surgical hypothesis. The pre-
surgical evaluation in this study revealed perifocal 18F-FDG
hypometabolism in 97% patients, which is consistent with the
published sensitivity of 85–96 % [5, 32, 45] and decreased
11C-FMZ binding in 81 % patients, which is also comparable
with reported sensitivity of 85–100 % for detecting the epi-
leptogenic cortex in patients with refractory TLE [19, 26, 27].
However, the automated quantitative evaluation in this study
showed superior findings and revealed perifocal 18F-FDG-
and 11C-FMZ abnormalities in all patients (100 %).
The findings of the automated quantitative 18F-FDG-
and 11C-FMZ PET evaluation
There is growing evidence that interictal 18F-FDG- and 11C-
FMZ PET may represent functional seizure-related phenome-
na in the underlying temporal lobe and the functionally asso-
ciated remote ipsilateral and contralateral regions [3, 6, 7, 16,
20, 21, 27, 32, 39, 41, 46, 48, 50–52] suggesting that the pre-
surgical glucose hypometabolism and decreased flumazenil-
binding pattern may be dynamic, seizure-related, and revers-
ible. In the light of this evidence, the findings in the current
series of cases are not surprising. We found that the pre-
surgical volume of perifocal 18F-FDG hypometabolism and
decreased 11C-FMZ binding in both VOIs did not influence
post-surgical seizure outcome (Tables 4 and 5) and had low
predictive values for the achievement of an Engel class I out-
come for each individual patient with refractory TLE (Tables 6
and 7). These findings in both VOIs of the temporal lobe are
consistent with the hypothesis that the area of perifocal 18F-
FDG hypometabolism and decreased 11C-FMZ binding often
indicate functionally impaired areas close to and often larger
than the seizure focus but do not necessarily represent epilep-
togenic cortex [22, 23].
Following resection, the pre-surgical volume of the
perifocal 18F-FDG- and 11C-FMZ PET abnormality in both
VOIs of the temporal lobe was considerably reduced
(Tables 2 and 3). However, the resected volumes of perifocal
18F-FDG- and 11C-FMZ PET abnormalities in both VOIs of
the temporal lobe were relatively small and seizure outcomes
were not affected by the amount of resected volume of
perifocal abnormalities in either VOIs (Tables 4 and 5). Fur-
thermore, the resected volumes had a low predictive value
with regard to individual freedom from seizures (Tables 6
and 7). Additional support for this view is provided in this
analysis demonstrating no substantial differences between
the outcome subgroups in the proportion of the non-resected
perifocal 18F-FDG hypometabolism and decreased 11C-FMZ
binding in both VOIs (Tables 4 and 5), which also had a weak
predictive value for individual freedom from seizures
(Tables 6 and 7).
The volumetric findings of the current series of patients
clearly suggest that complete resection of the pre-surgical
perifocal 18F-FDG- and 11C-FMZ PET abnormality areas in
the mesial structures of temporal lobe as well as in the entire
temporal lobe is not a prerequisite for a satisfactory post-
surgical seizure outcome in patients with drug-resistant TLE.
However, it remains unclear why resection of only a small
proportion of these abnormalities can result either in seizure
freedom in the majority of patients or in unsatisfactory out-
come in others.
Thus, our results support the idea that pre-surgical perifocal
18F-FDG- and 11C-FMZ PET abnormalities in both VOIs of
the temporal lobe cannot be used to delineate the margin of
surgical resection in these patients with TLE. Therefore, the
suggestion of tailored resection delineated on the basis of the
extent and severity of pre-surgical temporal lobe
hypometabolism in patients with refractory TLE [53] seems
questionable.
The findings of the automated quantitative evaluation
of the MRI-derived resected volume
The resection of epileptogenic tissue in the seizure onset tem-
poral lobe is a prerequisite for achieving freedom from dis-
abling seizures in patients with drug-resistant TLE. An ele-
ment of the procedural discussions in TLE surgery is whether
a reduced extent of resection is associated with a lower rate of
seizure freedom and vice versa. One objective of this study
was to assess the significance of the extent of resection of
mesial structures (VOIA+H+PH) and of the whole temporal lobe
(VOITL), determined by automated quantitative analysis, to
achieve seizure freedom after surgery for TLE. We compared
the MRI-derived resected tissue volume of the VOIA+H+PH
and VOITL and the proportion of the resected tissue volume
between the outcome subgroups and found no significant dif-
ferences (Tables 4 and 5). Furthermore, the results show that
the MRI-derived resected volume of the VOIA+H+PH and
VOITL as well as the proportion of this resected volume had
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a low predictive value for individual achievement of an Engel
class I outcome after undergoing AMTL (Tables 6 and 7).
These findings of the automated quantitative evaluation of
the MRI-derived resected volume of the current series of pa-
tients are not a novelty and are consistent with the previous
data in the literature, which showed that different surgical
approaches in TLE and different amounts of mesial temporal
resection do not result in different seizure outcomes [42, 43].
All patients with TLE in this cohort had on the pre-surgical
MRI, 18F-FDG, and 11C-FMZ PET studies positive findings
that corresponded with the epileptogenic temporal lobe as
defined with multiple EEGs. Despite this fact, there were
22 % of patients who continued to experience seizures after
surgery. It seems that the patients with TLE in this cohort do
not have a uniform epilepsy condition and that performing a
more or less Bstandardized^ AMTL may not always be suffi-
cient to remove all the tissue responsible for the occurrence of
seizures. As noted earlier [35], ideally, every single patient
with TLE should receive customized surgery to become sei-
zure-free. However, to define the individualized resection
margins more properly in patients with TLE, further diagnos-
tic improvements are warranted.
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